p73 cooperates with DNA damage agents to induce apoptosis in MCF7 cells in a p53-dependent manner (Q43700522)

26 November 2017

title

p73 cooperates with DNA damage agents to induce apoptosis in MCF7 cells in a p53-dependent manner (English)

1 reference

26 November 2017

0 references

J Zhu

1

1 reference

26 November 2017

S Nozell

2

1 reference

26 November 2017

J Wang

3

1 reference

26 November 2017

J Jiang

4

1 reference

26 November 2017

W Zhou

5

1 reference

26 November 2017

X Chen

6

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

26 November 2017

1 reference

26 November 2017

volume

20

1 reference

26 November 2017

issue

30

1 reference

26 November 2017

page(s)

4050-4057

1 reference

Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204516

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204516

The p53 family: same response, different signals?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204516

Two new p73 splice variants, gamma and delta, with different transcriptional activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204516

A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204516

The complexity of p53 modulation: emerging patterns from divergent signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204516

The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204516

14-3-3sigma is a p53-regulated inhibitor of G2/M progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204516

p73 is a simian [correction of human] p53-related protein that can induce apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204516

The emerging p53 gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204516

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204516

Monoallelically Expressed Gene Related to p53 at 1p36, a Region Frequently Deleted in Neuroblastoma and Other Human Cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204516

21 January 2018

p53: puzzle and paradigm

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204516

p53 mutations increase resistance to ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204516

p53, the cellular gatekeeper for growth and division

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204516

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204516

A common polymorphism acts as an intragenic modifier of mutant p53 behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204516

Viral oncoproteins discriminate between p53 and the p53 homolog p73.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204516

Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204516

Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204516

Apoptotic DNA fragmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204516

Identification of a novel class of genomic DNA-binding sites suggests a mechanism for selectivity in target gene activation by the tumor suppressor protein p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204516

Induced p53 expression in lung cancer cell line promotes cell senescence and differentially modifies the cytotoxicity of anti-cancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204516

An information-intensive approach to the molecular pharmacology of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204516

P63 and P73: P53 mimics, menaces and more

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204516

Identification and classification of p53-regulated genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204516

p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204516

Definition of the p53 functional domains necessary for inducing apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204516

Identification of a novel p53 functional domain that is necessary for mediating apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204516

Additional complexity in p73: induction by mitogens in lymphoid cells and identification of two new splicing variants ε and ζ

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204516

p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204516

7 January 2021

p73 function is inhibited by tumor-derived p53 mutants in mammalian cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204516

7 January 2021

p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204516

7 January 2021

p53 status and the efficacy of cancer therapy in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204516

7 January 2021

Induction of apoptosis in human lung cancer cells after wild-type p53 activation by methoxyestradiol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204516

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1204516

1 reference

Dimensions Publication ID

26 November 2017

1007158297

0 references

1 reference